This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
Centers of Excellence
Urologic Oncology
Left Group
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Kidney Cancer Today
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Translational Prostate Cancer
Women in Science
Andrea Miyahira, Ph.D
Health Policy
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Education
Covid-19
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Pelvic Health & Reconstruction
Endourology
Testicular Cancer
Health Policy in Urological Diseases
Clinical Trials
From the Editor
Search Clinical Trials
Trials in Progress
DORA - PCCTC
IRONMAN - PCCTC
PROMISE - PCCTC
SPLASH Trial
Oral EPI-7386
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2022
ASCO GU 2023
EAU 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
ASCO GU 2020
ASCO GU 2020
Prostate Cancer
Kidney Cancer
Bladder Cancer
Penile, Urethral, Testicular, and Adrenal Cancers
Press Releases
ASCO GU 2020 Penile, Urethral, Testicular, and Adrenal Cancers
Viewing 1-20 of 20 articles
ASCO GU 2020: Can Advanced Seminoma be Managed with a Risk Stratified Approach?
ASCO GU 2020: Evaluation of the Oncologic Benefit of Adjunctive Surgery at Time of Post-Chemotherapy Retroperitoneal Lymph Node Dissection
ASCO GU 2020: Intravesical Irrigation to Prevent Early Bladder Recurrence in Patients Undergoing Laparoscopic Radical Nephroureterectomy for Upper Urinary Tract Cancer
ASCO GU 2020: Atezolizumab Therapy for Upper Tract Urothelial Carcinoma: Subgroup Analysis of the Single-Arm International SAUL Study in Pretreated Locally Advanced/Metastatic Urinary Tract Carcinoma
ASCO GU 2020: Prognostic Factors in Advanced Seminoma — Analysis from the IGCCCG Update Consortium.
ASCO GU 2020: Chemotherapy/Radiation-Sparing Management Strategies for Early-Stage Germ Cell Tumors
ASCO GU 2020: Current Developments in Rare Urologic Malignancies: Are Biomarkers Going to Change the Future of Testicular Cancer?
ASCO GU 2020: SEMITEP: De-Escalating Chemotherapy in Low-Volume Metastatic Seminoma Based on Early FDG-PET
ASCO GU 2020: Prognostic Factors in Advanced Seminoma: An Analysis from the IGCCCG Update Consortium
ASCO GU 2020: The SEMITEP trial: De-Escalating Chemotherapy in Low-Volume Metastatic Seminoma Based on Early FDG-PET
ASCO GU 2020: PET Imaging in Penile Cancer
ASCO GU 2020: Developments in Rare Urologic Malignancies: Are biomarkers going to change the future of testicular cancer?
ASCO GU 2020: Comprehensive Genomic Profiling (CGP) of Histologic Subtypes of Urethral Carcinomas (UrthCa)
ASCO GU 2020: Management of Advanced/Poor Risk Testicular Cancer
ASCO GU 2020: Chemotherapy/Radiation-Sparing Management Strategies for Early-Stage Germ Cell Tumors - Urologists Perspective
ASCO GU 2020: Management of Advanced Poor-Risk Germ Cell Tumors
ASCO GU 2020: Are Biomarkers Going to Change the Future of Testicular Cancer?
ASCO GU 2020: Evaluation of the Oncologic Benefit of Adjunctive Surgery at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND)
ASCO GU 2020: Update on Positron Emission Tomography-Computed Tomography Imaging in Penile Cancer
ASCO GU 2020: Comprehensive Genomic Profiling of Histologic Subtypes of Urethral Carcinomas
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free